Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man

The beta-adrenergic selectivity of diacetolol, the major metabolite of acebutolol, has been compared with that of acebutolol, metoprolol and propranolol in 11 normal subjects. Bronchial and cardiac beta-adrenoceptor blockade were assessed on separate occasions after diacetolol 600 mg, acebutolol 400 mg, metoprolol 200 mg, propranolol 80 mg and placebo. Bronchial beta-adrenoceptor blockade was assessed as the displacement of the bronchodilator dose response curve to inhaled isoprenaline after each beta blocking drug compared to placebo and expressed as the dose ratio. Bronchodilatation was measured as change in specific airway conductance (sGaw) in the body plethysmograph. Cardiac beta-adrenoceptor blockade was assessed as the percentage reduction in exercise heart rate during the 5th minute of exercise at 70% of the subject's maximum work rate. There was a significant reduction in exercise heart rate with all 4 beta-blocking drugs when compared with placebo, 22% for diacetolol, 24% for acebutolol, 25% for propranolol and 28% for metoprolol. The reduction with metoprolol was significantly greater than the reduction with the other three beta-adrenoceptor antagonists. Mean dose ratios for the airway isoprenaline dose response curves after each of the 4 beta-blocking drugs were 2.4 for diacetolol, 2.7 for metoprolol, 8 for acebutolol and 72 for propranolol. The difference between diacetolol and metoprolol was not significant. Thus diacetolol appears to be more cardioselective than acebutolol and both are more cardioselective than propranolol in man. Metoprolol is probably more cardioselective than diacetolol though interpretation of the differences in exercise heart rate is complicated by the fact that diacetolol has some intrinsic sympathomimetic activity.

Nucleotide sequence and organisation of the gua promoter region of Escherichia coli

Overlapping restriction fragments of DNA carrying the gua promoter region of Escherichia coli have been cloned using promoter-probe plasmids. Antibiotic resistance conferred by the constructed plasmids is repressed by guanine and enhanced by adenine, two features characteristic of expression of the gua operon. The nucleotide sequence of these fragments reveals the gua promoter 43 bp upstream of the translational start codon for inosine 5'-monophosphate (IMP) dehydrogenase. The promoter is preceded by an A + T-rich region and several potential polymerase secondary binding sites, and is immediately followed by a G + C-rich discriminator, suggesting that the gua operon may be under stringent control. A sequence with twofold symmetry overlaps both promoter and discriminator and is therefore located where repressor binding could interfere with transcription initiation. A stem and loop can be formed from the leader mRNA, thus sequestering the ribosome-binding site.

Molecular cloning and characterisation of the gua regulatory region of Escherichia coli K12

The regulatory region of the gua operon of Escherichia coli is contained within a 2.1 kb EcoR1 restriction fragment isolated from a lambda pgua transducing phage. This DNA fragment was inserted into pPV33-II, a promoter-cloning vector, where it activated the gene(s) for tetracycline resistance. The level of tetracycline resistance conferred by the hybrid plasmid was reduced by the addition of guanine and increased by adenine, indicating the presence of the gua promoter. The cloned fragment codes for a polypeptide that complements in vivo the defective enzymes present in certain guaB mutants. This polypeptide was characterised using minicells and immunoprecipitation, and is presumed to correspond to the N-terminal region of IMP dehydrogenase.

[3H]Cholesteryl ester labeling and transfer among human and nonhuman primate plasma lipoproteins

Aliquots of human and nonhuman primate plasma containing 5,5'-dithiobis (2-nitrobenzoic acid) were incubated at 37 degrees C in tubes previously coated with trace amounts of tritium-labeled cholesteryl oleate ( [3H]CO). Initially, cholesteryl esters were transferred at a rapid rate into plasma after which the rate slowed. During 24 h of incubation, an average of 55% of the [3H]CO transferred from the side of the tube into African green monkey plasma, 44% into human plasma and 21% into rat plasma. Greater than 98% of the radioactive ester transferred into plasma was found to be associated with plasma lipoproteins that were then rapidly separated using vertical rotor density gradient ultracentrifugation. In very low density lipoprotein (VLDL)-poor plasma after 30 min incubations, high density lipoproteins (HDL) contained most of the [3H]CO while 5- to 24-h incubations resulted in increased labeling of low density proteins (LDL). In VLDL-rich plasma, it was found that in addition to the labeling of HDL, VLDL contained about 25% of the labeled cholesteryl esters after 30-min incubations and, as above, the proportion in LDL subsequently increased. Compositional analyses showed that intermediate-sized LDL (ILDL) were accumulating cholesteryl ester mass while transfer occurred. LDL labeled using this method were injected intravenously into monkeys and their removal from plasma was found to be similar to that found for LDL labeled in vivo. It was concluded that this method of plasma lipoprotein cholesteryl ester labeling, presumably a result of cholesteryl ester transfer protein activity, was efficient, resulted in lipoproteins labeled only in the cholesteryl ester moiety, and induced minimal modification of lipoprotein particles that did not alter their biological activity.

Asthma: A Risk Factor for Dental Caries?

This report points out a correlation between asthma and dental caries. It also gives certain guidelines on the measures to be taken in an asthmatic to negate the risk of dental caries.Key words: Asthma, Caries risk, Caries prevention, Dental cariesDOI: 10.3126/jnps.v30i3.3929J Nep Paedtr Soc 2010;30(3):175-176